IncFact
Company Profiles: Revenue, Growth, Competition

Geron Revenue, Growth & Competitor Profile

Last updated:

Company Awards

 
Public Company
public company
Fast Growing
Fastest Growing
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Geron

Access the complete profile.

Geron Fast Facts

Revenue$10 - $100 million    See Exact Annual Revenue
Employees10 - 100Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Address919 East Hillsdale Blv.d
Suite 250
Foster City, CA 94404

Note: Revenues for privately held companies are statistical evaluations.


Geron's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • Geron is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Geron Annual Revenue and Growth Rate

Geron Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 $10 - $100 million

Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Geron's revenues are gauged from an analysis of company filings.



Geron's Income Statement (based on Industry Averages)

Geron P&L$ Millions
Revenue (Sales) Geron Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Geron is developing and marketing. Geron doesn't have any recent trademark applications, indicating Geron is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
OSILVY
pharmaceuticals for the treatment, diagnosis or prophylaxis of human diseases, disorders and conditions, namely, cancer, and diseases, disorders and conditions of the hematological systems
09/16/2022
MTELIQ
pharmaceuticals for the treatment, diagnosis or prophylaxis of human diseases, disorders and conditions, namely, cancer, and diseases, disorders and conditions of the hematological systems
09/16/2022

See all trademarks and details in the Full Report.


Market Share of Geron's Largest Competitors

A competitive analysis shows these companies are in the same general field as Geron, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
LEIDOSDenver, CO100 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM30 
INC RESEARCHRaleigh, NC27 
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORKAlbany, NY17 
FLUOR MARINE PROPULSIONWest Mifflin, PA15 
SYNEOS HEALTHRaleigh, NC13 
ILLUMINASan Diego, CA12 
UT-BATTELLEOak Ridge, TN11 
PRA HOLDINGSRaleigh, NC11 




Nearby Competitors

These companies are similar in business line and location to Geron. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
CALA HEALTHSan Mateo, CA100 
CARGO THERAPEUTICSSan Mateo, CA93 
TRUEBINDINGFoster City, CA62 
GERONFoster City, CA50 
ROUTE 92 MEDICALSan Mateo, CA33 
STOTTLER HENKE ASSOCIATESSan Mateo, CA19 




Future Competition: Geron's Fastest Growing Competitors

These companies are in the same general field as Geron and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Geron Competitors